Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Morris

Showing results (121-130 of 324) with videos related to

Pageof 33
Sort By:
Journal of Virology|June 27, 2022
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing AntibodiesDaniel J Sheward, Tandile Hermanus, Ben Murrell, et al.
The International Journal of Cardiovascular Imaging|December 10, 2017
CT based 3D printing is superior to transesophageal echocardiography for pre-procedure planning in left atrial appendage device closureEdinrin Obasare, Sumeet K Mainigi, D Lynn Morris, et al.
Antimicrobial Agents and Chemotherapy|February 3, 2016
Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based TherapyJennifer Giandhari, Adriaan E Basson, Katherine Sutherland, et al.
JNCI Cancer Spectrum|November 2, 2020
Health Behaviors of Cancer Survivors and Population Controls From the National Health Interview Survey (2005-2015)Patrick Boyd, Mark Lowry, Kasey Lynn Morris, et al.
Journal of Virology|December 21, 2007
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody responseElin S Gray, Penny L Moore, Frederic Bibollet-Ruche, et al.
Journal of Virology|December 7, 2007
The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infectionPenny L Moore, Elin S Gray, Isaac A Choge, et al.
Journal of Infection in Developing Countries|July 16, 2014
Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, TanzaniaFausta Mosha, Johanna Ledwaba, Faustine Ndugulile, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2014
Novel indole based NNRTIs with improved potency against wild type and resistant HIVRonel Müller, Iqbal Mulani, Adriaan E Basson, et al.
Echocardiography (Mount Kisco, N.Y.)|March 2, 2017
Natural history of severe aortic stenosis: Diastolic wall strain as a novel prognostic markerEdinrin Obasare, Vikas Bhalla, Deepakraj Gajanana, et al.
Journal of Virology|February 15, 2013
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodiesPenny L Moore, Daniel Sheward, Molati Nonyane, et al.
Pageof 33

Showing results (121-130 of 324) with videos related to

Sort By:
Pageof 33
Journal of Virology|June 27, 2022
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing AntibodiesDaniel J Sheward, Tandile Hermanus, Ben Murrell, et al.
The International Journal of Cardiovascular Imaging|December 10, 2017
CT based 3D printing is superior to transesophageal echocardiography for pre-procedure planning in left atrial appendage device closureEdinrin Obasare, Sumeet K Mainigi, D Lynn Morris, et al.
Antimicrobial Agents and Chemotherapy|February 3, 2016
Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based TherapyJennifer Giandhari, Adriaan E Basson, Katherine Sutherland, et al.
JNCI Cancer Spectrum|November 2, 2020
Health Behaviors of Cancer Survivors and Population Controls From the National Health Interview Survey (2005-2015)Patrick Boyd, Mark Lowry, Kasey Lynn Morris, et al.
Journal of Virology|December 21, 2007
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody responseElin S Gray, Penny L Moore, Frederic Bibollet-Ruche, et al.
Journal of Virology|December 7, 2007
The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infectionPenny L Moore, Elin S Gray, Isaac A Choge, et al.
Journal of Infection in Developing Countries|July 16, 2014
Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, TanzaniaFausta Mosha, Johanna Ledwaba, Faustine Ndugulile, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2014
Novel indole based NNRTIs with improved potency against wild type and resistant HIVRonel Müller, Iqbal Mulani, Adriaan E Basson, et al.
Echocardiography (Mount Kisco, N.Y.)|March 2, 2017
Natural history of severe aortic stenosis: Diastolic wall strain as a novel prognostic markerEdinrin Obasare, Vikas Bhalla, Deepakraj Gajanana, et al.
Journal of Virology|February 15, 2013
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodiesPenny L Moore, Daniel Sheward, Molati Nonyane, et al.
Pageof 33